/
CDXS
$1.60+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$175.2M
110M shares
52-week range
$0.96 – $3.87
22% from low
Sector
INDUSTRIAL ORGANIC CHEMICALS
Exchange
NASDAQ
CS
Change$-21.58
Codexis, Inc.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
www.codexis.com- Employees
- 146
- IPO / List date
- Apr 22, 2010
- HQ
- REDWOOD CITY, CA
Held by traders on TradeandTell
No one on the platform currently holds CDXS.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 198,733 | $323.9K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded CDXS yet.
